Correlation between clinical nodal status and sentinel lymph node biopsy false negative rate after neoadjuvant chemotherapy

World Journal of Surgery

Volumn 36, Issue 12, 2012, Pages 2847-2852

  Takahashi, Maiko ^a   Jinno, Hiromitsu ^a   Hayashida, Tetsu ^a   Sakata, Michio ^a   Asakura, Keiko ^a   Kitagawa, Yuko ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLA; BREAST TUMOR; CANCER STAGING; EVALUATION; FEASIBILITY STUDY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LYMPH NODE DISSECTION; MIDDLE AGED; PATHOLOGY; SEGMENTAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FALSE NEGATIVE REACTIONS; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 84877294314     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1704-z     Document Type: Article

References (23)

1. Fisher B, Jeong JH, Anderson S et al (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567-575
2. Orr RK (1999) The impact of prophylactic axillary node dissection on breast cancer survival-a Bayesian meta-analysis. Ann Surg Oncol 6:109-116
3. Giuliano AE, Kirgan DM, Guenther JM et al (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398 discussion 398-401
4. Albertini JJ, Lyman GH, Cox C et al (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822
5. Fisher B, Bryant J, Wolmark N et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685
6. Bonadonna G, Veronesi U, Brambilla C et al (1990) Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82:1539-1545
7. Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483-2493
8. Fisher B, Mamounas EP (1995) Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. J Clin Oncol 13:537-540
9. Kuerer HM, Newman LA (2005) Lymphatic mapping and sentinel lymph node biopsy for breast cancer: developments and resolving controversies. J Clin Oncol 23:1698-1705
10. Schwartz GF, Hortobagyi GN (2003) Committee CC proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast. April 26-28, 2003, Philadelphia, Pennsylvania. Cancer 100:2512-2532
11. Sharkey FE, Addington SL, Fowler LJ et al (1996) Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 9:893-900
12. Fisher ER, Wang J, Bryant J et al (2002) Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-18. Cancer 95:681-695
13. Mamounas EP, Brown A, Anderson S et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23:2694-2702
14. Xing Y, Foy M, Cox DD et al (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93:539-546
15. Kuerer HM, Sahin AA, Hunt KK et al (1999) Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230:72-78
16. Fraile M, Rull M, Julian FJ et al (2000) Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 11:701-705
17. Miltenburg DM, Miller C, Karamlou TB et al (1999) Metaanalysis of sentinel lymph node biopsy in breast cancer. J Surg Res 84:138-142
18. Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106:4-16
19. Le Bouedec G, Gauthier T, Gimbergues P et al (2008) Axillary recurrence after negative sentinel lymph node biopsy in breast cancer. Presse Med 37:1685-1687
20. Tausch C, Konstantiniuk P, Kugler F et al (2006) Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian sentinel node study Group. Ann Surg Oncol 15:3378-3383
21. Shen J, Gilcrease MZ, Babiera GV et al (2007) Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109:1255-1263
22. Lee S, Kim EY, Kang SH et al (2007) Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat 102:283-288
23. Kinoshita T, Takasugi M, Iwamoto E et al (2006) Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Am J Surg 191:225-229